SECURITIES AND EXCHANGE COMMISSION
WASHINGTON D.C. 20549
FORM 10-Q
QUARTERLY REPORT UNDER SECTION 13 OR 15 (d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarter ended September 30, 2010
Commission File Number 0-10683
HYDROMER, INC.
--------------
(Exact name of registrant as specified in its charter)
New Jersey 22-2303576
---------------------- -------------------------
(State of incorporation) (I.R.S. Employer
Identification No.)
35 Industrial Pkwy, Branchburg, New Jersey 08876-3424
------------------------------------------ -------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (908) 722-5000
-------------------------
Securities registered pursuant to Section 12 (b) of the Act: None
Securities registered pursuant to Section 12 (g) of the Act:
Common Stock Without Par Value
(Title of class)
Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such report(s), and (2) has been subject to such
filing requirements for the past 90 days. [X] Yes [ ] No
Indicate by check mark whether the registrant is a large accelerated filer,
an accelerated filer, a non-accelerated filer, or a smaller reporting company.
Large accelerated filer [ ] Accelerated filer [ ]
Non-accelerated filer [ ] Smaller reporting company [X]
Indicate by check mark whether the registrant is a shell company (as defined
in Rule 12b-2 of the Exchange Act).
Yes [ ] No [X]
Class Outstanding at September 30, 2010
----- ---------------------------------
Common 4,772,318
--------------------------------------------------------------------------------
FORWARD-LOOKING STATEMENTS
This quarterly report on Form 10-Q contains forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the
Securities Exchange Act of 1934. Forward-looking statements include, among other
things, business strategy and expectations concerning industry conditions,
market position, future operations, margins, profitability, liquidity and
capital resources. Forward-looking statements generally can be identified by the
use of terminology such as "may," "will," "expect," "intend," "estimate,"
"anticipate" or "believe" or similar expressions or the negatives thereof. These
expectations are based on management's assumptions and current beliefs based on
currently available information. Although the Company believes that the
expectations reflected in such statements are reasonable, it can give no
assurance that such expectations will be correct. You are cautioned not to place
undue reliance on these forward-looking statements, which speak only as of the
date of this quarterly report on Form 10-Q and the Company does not have any
obligation to update the forward looking statements. The Company's operations
are subject to a number of uncertainties, risks and other influences, many of
which are outside its control, and any one of which, or a combination of which,
could cause its actual results of operations to differ materially from the
forward-looking statements.
1
HYDROMER, INC.
INDEX TO FORM 10-Q
September 30, 2010
Page No.
Part I - Financial Information
# 1 Consolidated Financial Statements
Balance Sheets - September 30, 2010 & June 30, 2010 3
Statements of Operations for the three months ended 4
September 30, 2010 and 2009
Statements of Cash Flows for the three months ended
September 30, 2010 and 2009 5
Notes to Financial Statements 6
# 2 Management's Discussion and Analysis of the Financial
Condition and Results of Operations 7
# 3 Controls and Procedures 9
Part II - Other Information
# 1 Legal Proceedings N/A
# 2 Change in Securities N/A
# 3 Default of Senior Securities N/A
# 4 Submission of Motion to Vote of Security Holders N/A
# 5 Other Information N/A
# 6 Exhibits 9
EXHIBIT INDEX
Exhibit No. Description of Exhibit
----------- ----------------------
31.1 SEC Section 302 Certification - CEO certification 10
31.2 SEC Section 302 Certification - CFO certification 11
32.1 Certification of Manfred F. Dyck, Chief Executive
Officer, pursuant to 18 U.S.C. Section 1350 12
32.2 Certification of Robert Y. Lee, Chief Financial
Officer, pursuant to 18 U.S.C. Section 1350 12
2
PART I - CONSOLIDATED FINANCIAL STATEMENTS
ITEM # 1
HYDROMER, INC. AND CONSOLIDATED SUBSIDIARY
CONSOLIDATED BALANCE SHEETS
September 30, June 30,
2010 2010
UNAUDITED AUDITED
ASSETS
Current Assets:
Cash and cash equivalents $ 967,109 $ 843,610
Short-term investments - 440,000
Trade receivables less allowance for doubtful accounts of
$31,817 and $33,276 as of September 30, 2010 and June 30, 856,690 920,252
2010, respectively
Inventory 326,642 248,569
Prepaid expenses 166,178 227,338
Other 3,236 15,487
----------------------------------------------------------------------------------------------------------
Total Current Assets 2,319,855 2,695,256
----------------------------------------------------------------------------------------------------------
Property and equipment, net 2,979,151 2,988,536
Deferred tax asset, non-current 1,176,873 1,011,945
Intangible assets, net 852,888 839,722
----------------------------------------------------------------------------------------------------------
Total Assets $ 7,328,767 $ 7,535,459
----------------------------------------------------------------------------------------------------------
LIABILITIES AND STOCKHOLDERS' EQUITY
Current Liabilities:
Accounts payable $ 330,976 $ 342,030
Accrued expenses 303,530 251,276
Current portion of capital lease 16,407 16,000
Current portion of deferred revenue 95,547 75,828
Current portion of mortgage payable 49,547 48,800
----------------------------------------------------------------------------------------------------------
Total Current Liabilities 796,007 733,934
----------------------------------------------------------------------------------------------------------
Deferred tax liability 318,375 318,375
Long-term portion of capital lease 30,106 34,716
Long-term portion of deferred revenue 169,461 165,813
Long-term portion of mortgage payable 2,756,182 2,769,036
----------------------------------------------------------------------------------------------------------
Total Liabilities 4,070,131 4,021,874
----------------------------------------------------------------------------------------------------------
Stockholders' Equity
Preferred stock - no par value, authorized 1,000,000 shares, no
shares issued and outstanding - -
Common stock - no par value, authorized 15,000,000 shares;
4,783,235 shares issued and 4,772,318 shares outstanding as
of September 30, 2010 and June 30, 2010 3,721,815 3,721,815
Contributed capital 633,150 633,150
Accumulated deficit (1,090,189) (835,240)
Treasury stock, 10,917 common shares at cost (6,140) (6,140)
----------------------------------------------------------------------------------------------------------
Total Stockholders' Equity 3,258,636 3,513,585
----------------------------------------------------------------------------------------------------------
Total Liabilities and Stockholders' Equity $ 7,328,767 $ 7,535,459
----------------------------------------------------------------------------------------------------------
See accompanying notes
3
HYDROMER, INC. AND CONSOLIDATED SUBSIDIARY
CONSOLIDATED STATEMENTS OF OPERATIONS
Three Months Ended
September 30,
2010 2009
UNAUDITED UNAUDITED
------------------------------------------------ -----------------------------
REVENUES
Sale of products $ 650,404 $ 1,181,704
Service revenues 369,321 299,792
Royalties and contract revenues 236,167 228,075
------------------------------------------------ -----------------------------
TOTAL REVENUES
1,255,892 1,709,571
------------------------------------------------ -----------------------------
EXPENSES
Cost of Sales 426,599 840,194
Operating Expenses 1,199,292 1,266,360
Other Expenses 49,879 51,614
Benefit from Income Taxes (164,928) (176,209)
------------------------------------------------ -----------------------------
1,510,842 1,981,959
TOTAL EXPENSES
------------------------------------------------ -----------------------------
NET LOSS $ (254,950) $ (272,388)
------------------------------------------------ -----------------------------
Loss Per Common Share $ (0.05) $ (0.06)
Weighted Average Number of
Common Shares Outstanding 4,772,318 4,772,318
See accompanying notes.
There was no impact to earnings per share from dilutive securities as the resultant
would have been anti-dilutive.
4
HYDROMER, INC. AND CONSOLIDATED SUBSIDIARY
CONSOLIDATED STATEMENTS OF CASH FLOWS
Three months Ended
September 30,
2010 2009
UNAUDITED UNAUDITED
-----------------------------------------------------------------------------------------------------
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Loss $ (254,950) $ (272,388)
Adjustments to reconcile net loss to net cash in for
operating activities
Depreciation and amortization 101,244 101,428
Deferred income taxes (164,928) (177,564)
Changes in Assets and Liabilities:
Trade receivables 63,562 (22,970)
Inventory (78,073) (5,370)
Prepaid expenses 41,790 42,932
Other assets 12,398 414
Accounts payable and accrued liabilities 41,200 49,914
Deferred income 23,367 9,968
Income taxes payable - (60,000)
-----------------------------------------------------------------------------------------------------
Net Cash Used in Operating Activities (214,390) (333,636)
-----------------------------------------------------------------------------------------------------
CASH FLOWS FROM INVESTING ACTIVITIES:
Cash purchases of property and equipment (46,896) (65,010)
Cash payments on patents and trademarks (43,108) (83,207)
Redemption of matured short-term investments 440,000 260,000
Cash purchases of short-term investments - (250,000)
-----------------------------------------------------------------------------------------------------
Net Cash Provided by (Used in) Investing Activities 349,996 (138,217)
-----------------------------------------------------------------------------------------------------
CASH FLOWS FROM FINANCING ACTIVITIES:
Repayment of long-term borrowings (12,107) (11,276)
-----------------------------------------------------------------------------------------------------
Net Cash Used in Financing Activities (12,107) (11,276)
-----------------------------------------------------------------------------------------------------
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS: 123,499 (483,129)
Cash and Cash Equivalents at Beginning of Period 843,610 1,585,765
-----------------------------------------------------------------------------------------------------
Cash and Cash Equivalents at End of Period $ 967,109 $ 1,102,636
-----------------------------------------------------------------------------------------------------
See accompanying notes.
5
HYDROMER, INC. AND CONSOLIDATED SUBSIDIARY
Notes to Consolidated Financial Statements
In the opinion of management, the accompanying unaudited financial statements
include all adjustments (consisting of only normal adjustments) necessary for a
fair presentation of the results for the interim periods. Certain
reclassifications have been made to the previous year's results to present
comparable financial statements.
Fair Value:
Some of the Company's financial instruments are not measured at fair value on a
recurring basis but are recorded at amounts that approximate fair value due to
their liquid or short-term nature, such as cash and cash equivalents,
receivables and payables. The carrying amount of the mortgage is consistent with
the terms available in the market for instruments with similar risk.
Segment Reporting:
The Company operates two primary business segments. The Company evaluates the
segments by revenues, total expenses and earnings before taxes. Corporate
Overhead (primarily the salaries and benefits of senior management, support
services (Accounting, Legal, Human Resources and Purchasing) and other shared
services (building maintenance and warehousing) is excluded from the business
segments as to not distort the contribution of each segment. These segments are
the lowest levels for which identifiable cash flows are largely independent of
the cash flows of other assets and liabilities.
The results for the three months ended September 30, by segment are:
Polymer Medical Corporate
Research Products Overhead Total
2010
Revenues $ 921,326 $ 334,566 $ 1,255,892
Expenses (980,130) (246,837) $ (448,803) (1,675,770)
----------- ----------- ------------ -------------
Pre-tax Income (Loss) $ (58,804) $ 87,729 $ (448,803) $ (419,878)
=========== =========== ============ =============
2009
Revenues $ 962,136 $ 747,435 $ 1,709,571
Expenses (966,814) (788,962) $ (402,392) (2,158,168)
----------- ----------- ------------ -------------
Pre-tax Income (Loss) $ (4,678) $ (41,527) $ (402,392) $ (448,597)
=========== =========== ============ =============
Geographic revenues were as follows for the three months ended September 30,
2010 2009
---- ----
Domestic 64% 76%
Foreign 36% 24%
6
ITEM #2
MANAGEMENT'S DISCUSSION AND ANALYSIS OF THE
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Results of Operations
The Company's revenues for the quarter ended September 30, 2010 were $1,255,892,
$453,679 or 26.5% lower than the $1,709,571 for the same period the previous
year. Revenues are comprised of the sale of Products and Services and Royalty
and Contract payments.
Product sales were $650,404 for the quarter ended September 30, 2010 as
compared to $1,181,704 for the same period the year before, a $531,300
(45.0%) decrease; lower due to the impact from the sales of product lines
to Merit Medical Systems, Inc. ("Merit") in February 2009 and to Forefront
Medical Technology (PTE) LTD ("Forefront") in November 2009. Including the
transition period in which we continued to manufacture products on the
behalf of Merit and Forefront until October 2009 and April 2010,
respectively, the product lines sold accounted for $515,845 of product
sales during the quarter ended September 30, 2009. We expect revenues from
our recently launched Dragonhyde(R) Hoof Bath Concentrates ("HBC") product
to more than replace the lost revenues from the sold OEM product lines
later in calendar 2011.
Services revenues for the three months ended September 30, 2010 was
$369,321 or $69,529 higher (23.2%) than the $299,792 the corresponding
period the year before. Increased demand for our services accounted for
the increase.
Royalty and Contract revenues include royalties received and the periodic
recurring payments from license, stand still and other agreements for
other than product and services. Included in Royalty and Contract revenues
are revenues from support and supply agreements. Some of the royalties and
support fees are based on the net sales of the final item (to which the
Hydromer technology is applied to) and are subject to the reporting of our
customers. For the quarter ended September 30, 2010, Royalty and Contract
revenues were $236,167, compared to $228,075 the same period a year ago.
It is anticipated that this revenue line will at least double within a few
years as a result of one of our hydrogel technologies that has been under
testing the past few years.
In summary, we are at a conversion period on our revenue mix, moving away
from the lower margin OEM product lines that were sold, to the T-HEXX(R)
Animal Health product line that we have been enriching the past few years,
including with the Dragonhyde HBC developed and launched recently.
Total Expenses for the quarter ended September 30, 2010 were $1,510,842 as
compared with $1,981,959 the year before, a 23.8% decrease.
For the quarter ended September 30, 2010, the Company's Cost of Goods Sold
was $426,599 as compared with $840,194 the year prior, lower by $413,595
or 49.2%. The Cost of Goods Sold attributed to the sold product lines were
approximately $424,000 in the September 2009 quarter.
Operating expenses were $1,199,292 for the quarter ended September 30,
2010 as compared with $1,266,360 the year before, lower by $67,068 or
5.3%. We expect Operating expenses to not change dramatically from its
current level with increases anticipated for marketing and promotions
activity, primarily from the increased focus in our T-HEXX Animal Health
business, including added international tradeshow promotions and related
travel and marketing expenditures, offset by other reductions in operating
expenses (including reduced patent funding on a cash basis, but not on an
amortization basis).
Interest expense, interest income and other income are included in Other
Expenses. Interest expense (on the mortgage) for the three months ended
September 30, 2010 and September 30, 2009 were $51,679 and $53,035,
respectively.
A net loss of $254,950 ($0.05 per share) is reported for the quarter ended
September 30, 2010 as compared to a net loss of $272,388 ($0.06 per share) the
year before.
The sale of the OEM product lines had a direct impact to our current
year's results by at least $91,000 (reduced revenues less direct costs of
7
sales). Thus when adjusting for the sold OEM product lines, there is a
greater improvement to the operations this year.
Financial Condition
Working capital decreased $437,474 during the three months ended September 30,
2010.
Net operating activities used $214,390 during the three month period ended
September 30, 2010.
The net loss, as adjusted for non-cash expenses of depreciation and
amortization and deferred income taxes, used $318,634 in cash. The net
change in other operating assets and liabilities provided for $104,244 in
cash, primarily from the collection of trade receivables, increase in
accrued liabilities and expensing of prepaid expenses as offset by an
inventory buildup related to the Dragonhyde HBC product launch.
Investing activities provided $349,996 and financing activities used $12,107
during the three months ended September 30, 2010.
Investing activities for the three months ended September 30, 2010
included $46,896 for capital expenditures and $43,108 towards the
Company's patent estate. $440,000 in short-term investments matured and
was converted into cash. The Financing activities was the repayment of the
principal portion of the mortgage.
Over the next few years, if not this fiscal year alone, we expect the demand for
the T-HEXX product lines to increase, replacing the lost income from the
cancellation of the $100,000 per month Supply and Support Agreement (in January
2009 and replaced with a $35,000 per month agreement) and from the sale of OEM
product lines. For example, replacement revenues coming from the sales of the
recently introduced Dragonhyde HBC product, which is cost comparative to
competing Copper Sulfate and much more environmentally and user friendly than
formalin (formaldehyde). In addition, there are other new or increased revenue
channels foreseen, including that from its anti-microbial, anti-thrombogenic and
cell mitosis technologies, however those are further downstream and there is no
assurance these future expectations will occur. Nonetheless, the Company has a
strong balance sheet to meet its required debt servicing.
8
ITEM # 3
Disclosure Controls and Procedures
As of the period covered by this report, the Company carried out an
evaluation, under the supervision and with the participation of our management,
including the Chief Executive Officer and President and the Chief Financial
Officer, of the effectiveness of the design and operation of the disclosure
controls and procedures.
Based upon this evaluation, our Chief Executive Officer and Chief Financial
Officer concluded that, our disclosure controls and procedures were effective
and that there were no changes to our Company's internal control over financial
reporting that have materially affected, or is reasonably likely to materially
affect the Company's internal control over financial reporting during the period
covered by the Company's quarterly report.
PART II - OTHER INFORMATION
The Company operates entirely from its sole location at 35 Industrial Parkway
in Branchburg, New Jersey, an owned facility secured by a mortgage through a
bank.
The existing facility will be adequate for the Company's operations for the
foreseeable future.
ITEM # 6. Exhibits
Exhibit No. Description
----------- -----------
31.1 Rule 13a-14(a) Certification of Chief Executive Officer
and President
31.2 Rule 13a-14(a) Certification of Vice President of Finance
and Chief Financial Officer
32.1 Section 1350 Certification of Chief Executive Officer
and Chairman, President
32.2 Section 1350 Certification of Chief Financial Officer and
Vice President of Finance
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on his behalf by the
undersigned thereunto duly authorized.
HYDROMER, INC.
/s/ Robert Y. Lee, VP
--------------------
Robert Y. Lee
Principal Accounting Officer &
Chief Financial Officer
DATE: November 9, 2010
9
EXHIBIT 31.1
I, Manfred F. Dyck, certify that:
1. I have reviewed this quarterly report on Form 10-Q of Hydromer, Inc.;
2. Based on my knowledge, this quarterly report does not contain any untrue
statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which
such statements were made, not misleading with respect to the period
covered by this quarterly report;
3. Based on my knowledge, the financial statements, and other financial
information included in this quarterly report, fairly present in all
material respects the financial condition, results of operations and
cash flows of the registrant as of, and for, the periods presented in
this quarterly report;
4. The registrant's other certifying officer, Mr. Robert Y. Lee and I am
responsible for establishing and maintaining disclosure controls and
procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e))
and internal control over financial reporting (as defined in Exchange
Act Rules 13a-15(f) and 15d-15(f) for the registrant and have:
a) designed such disclosure controls and procedures, or caused such
disclosure controls and procedures to be designed under our
supervision, to ensure that material information relating to the
registrant, including its consolidated subsidiaries, is made known to
us by others within those entities, particularly during the period in
which this quarterly report is being prepared;
b) designed such internal controls over financial reporting, or caused
such internal controls over financial reporting to be designed under
our supervision, to provide reasonable assurances regarding the
reliability of financial reporting and the preparation of financial
statements for external purposes in accordance with generally accepted
accounting principles
c) evaluated the effectiveness of the registrant's disclosure controls and
procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end
of the period covered by this report based on such evaluation; and
d) disclosed in this report any change in the registrant's internal
control over financial reporting that occurred during the registrant's
most recent fiscal quarter (the registrant's fourth fiscal quarter in
case of an annual report) that has materially affected, or is
reasonably likely to materially affect, the registrant's internal
control over financial reporting;
5. The registrant's other certifying officer, Mr. Robert Y. Lee and I have
disclosed, based on our most recent evaluation, to the registrant's
auditors and the audit committee of registrant's board of directors (or
persons performing the equivalent functions):
a) all significant deficiencies in the design or operation of internal
controls which could adversely affect the registrant's ability to
record, process, summarize and report financial data and have
identified for the registrant's auditors any material weaknesses in
internal controls; and
b) any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant's internal
controls; and
6. The registrant's other certifying officer, Mr. Robert Y. Lee and I have
indicated in this quarterly report whether there were significant
changes in internal controls or in other factors that could
significantly affect internal controls subsequent to the date of our
most recent evaluation, including any corrective actions with regard to
significant deficiencies and material weaknesses.
Date: November 9, 2010
/s/ Manfred F. Dyck
--------------------------------------
Manfred F. Dyck, President and CEO
EXHIBIT 31.2
I, Robert Y. Lee, certify that:
1. I have reviewed this quarterly report on Form 10-Q of Hydromer, Inc.;
2. Based on my knowledge, this quarterly report does not contain any untrue
statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which
such statements were made, not misleading with respect to the period
covered by this quarterly report;
3. Based on my knowledge, the financial statements, and other financial
information included in this quarterly report, fairly present in all
material respects the financial condition, results of operations and
cash flows of the registrant as of, and for, the periods presented in
this quarterly report;
4. The registrant's other certifying officer, Mr. Manfred F. Dyck and I am
responsible for establishing and maintaining disclosure controls and
procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e))
and internal control over financial reporting (as defined in Exchange
Act Rules 13a-15(f) and 15d-15(f) for the registrant and have:
a) designed such disclosure controls and procedures, or caused such
disclosure controls and procedures to be designed under our
supervision, to ensure that material information relating to the
registrant, including its consolidated subsidiaries, is made known to
us by others within those entities, particularly during the period in
which this quarterly report is being prepared;
b) designed such internal controls over financial reporting, or caused
such internal controls over financial reporting to be designed under
our supervision, to provide reasonable assurances regarding the
reliability of financial reporting and the preparation of financial
statements for external purposes in accordance with generally accepted
accounting principles
c) evaluated the effectiveness of the registrant's disclosure controls and
procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end
of the period covered by this report based on such evaluation; and
d) disclosed in this report any change in the registrant's internal
control over financial reporting that occurred during the registrant's
most recent fiscal quarter (the registrant's fourth fiscal quarter in
case of an annual report) that has materially affected, or is
reasonably likely to materially affect, the registrant's internal
control over financial reporting;
5. The registrant's other certifying officer, Mr. Manfred F. Dyck and I
have disclosed, based on our most recent evaluation, to the registrant's
auditors and the audit committee of registrant's board of directors (or
persons performing the equivalent functions):
a) all significant deficiencies in the design or operation of internal
controls which could adversely affect the registrant's ability to
record, process, summarize and report financial data and have
identified for the registrant's auditors any material weaknesses in
internal controls; and
b) any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant's internal
controls; and
6. The registrant's other certifying officer, Mr. Manfred F. Dyck and I
have indicated in this quarterly report whether there were significant
changes in internal controls or in other factors that could
significantly affect internal controls subsequent to the date of our
most recent evaluation, including any corrective actions with regard to
significant deficiencies and material weaknesses.
Date: November 9, 2010
/s/ Robert Y. Lee,VP
--------------------------------------
Robert Y. Lee, Vice President of Finance and CFO
EXHIBIT 32.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Manfred F. Dyck, certify, pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly
Report of Hydromer, Inc. on Form 10-Q for the three months ended September 30,
2010 fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934 and that information contained in such report
fairly presents in all material respects the financial condition and results of
operations of Hydromer, Inc.
Date: November 9, 2010 By: /s/ Manfred F. Dyck
Manfred F. Dyck
Chairman, President and
Chief Executive Officer
--------------------------------------------------------------------------------
EXHIBIT 32.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Robert Y. Lee, certify, pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly
Report of Hydromer, Inc. on Form 10-Q for the three months ended September 30,
2010 fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934 and that information contained in such report
fairly presents in all material respects the financial condition and results of
operations of Hydromer, Inc.
Date: November 9, 2010 By: /s/ Robert Y. Lee,VP
Robert Y. Lee
Chief Financial Officer and
Vice President of Finance